Search
Searching Content indexed under Food and Drugs Law by Reed Smith (Worldwide) ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Cannabis In The UK – A Regulatory Environment In Transition?
Recently, three British MPs went to Canada on a fact-finding cross-party trip to consider the effects of a more relaxed regulatory environment in respect of cannabis.
UK
19 Aug 2019
2
China Continues To Sharpen Its Teeth Against Corruption: Updates To China's Anti-Corruption Regime
The first half of 2018 saw a number of significant changes to the Chinese anti-corruption regime, including amendments to the Anti-Unfair Competition Law and formation of new anti-corruption regulatory bodies.
China
18 Sep 2018
3
The "French Bribery Act" That Is Soon To Be Enacted
The last version of the "French Bribery Act" gives more shape to the new provisions of the law and confirms that it contemplates to substantially change the legal anti-corruption scope in France.
France
10 Dec 2016
4
French Supreme Court Ruling Clarifies Liability For Defective Products
In the case at hand, a patient was prescribed Mediator, an appetite suppressant, between 1998 and 2008.
France
16 Jun 2016
5
French Bribery Act Would Be Anti-Corruption Revolution
We've covered the French Sunshine Act, which requires French pharmaceutical companies to disclose their links to healthcare providers, extensively over the past few years.
France
29 Feb 2016
6
Defective Products: Anxiety Damage Recognised And Provisionally Compensated By Interim Relief Judge
By three court orders issued on 28 January 2016, the Nanterre Civil Court interim relief judge (Juge des référés du Tribunal de grande instance de Nanterre) granted a provision to 13 patients who had taken the Médiator® drug...
France
11 Feb 2016
7
Amarin Pharma v. FDA – More Briefs Filed Regarding Off-Label Promotion And The First Amendment
Our prior posts looked at the Amarin Pharma, Inc. v. United States Food and Drug Administration lawsuit, which raises issues regarding the First Amendment and how it applies to speech by drug and device manufacturers regarding "off-label" uses.
UK
4 Jul 2015
8
French Sunshine Act's Scope Expands With Recent French Supreme Administrative Court Decision
Reed Smith’s Global Regulatory Enforcement Law Blog features a post on a recent decision by the French Supreme Administrative Court (Conseil d’Etat) that expands the scope of the French Sunshine Act.
France
19 Mar 2015
9
French Supreme Administrative Court Decision Significantly Broadens Scope Of The French ‘Sunshine Act’
On 24 February 2015, the French Supreme Administrative Court (Conseil d’Etat) reached a landmark decision which significantly expands the scope of the so-called French Sunshine Act.
France
18 Mar 2015
10
European Clinical Trial Regulations Public Consultation – Confidentiality Concerns
Clinical Trial Regulations On 21 January 2015, the European Medicines Agency (EMA) began a public consultation on the new European Clinical Trial Regulations (CTRs).
European Union
18 Feb 2015
11
Sobering Action: Immediate Ban For Irresponsible Drinking Ad
The ASA has taken the "unusual step" of immediately removing an ad by a company called Koosday for a club night.
UK
9 Jul 2014
12
Was It Worth The Wait? - FDA Releases Two Social Media Guidance Documents For Drug/Device Industry
Earlier this week, the FDA issued two draft guidances on social media.
UK
24 Jun 2014
13
New UK Pharmaceutical Packaging Warnings: Lucy In The Sky With Directions For Marketing Authorisation Holders
This client alert looks at the impact of a new drug driving offence in the UK which will come into effect during 2014 as part of The Crime and Courts Act 2013 (the "CCA 2013").
UK
20 Feb 2014
14
Botox Ads Frozen By The ASA
Following a complaint from the Independent Healthcare Advisory Service, the ASA has banned botox ads by Dermaskin and HB Health of Knightsbridge.
UK
23 Jan 2014
15
Planes, Trains And Over-The-Counter Pills
This Reed Smith client alert looks at the recent amendments to the Human Medicines Regulations 2012, which came into force in November 2013.
UK
19 Dec 2013
16
Draft FDA Guidance Recommends Cybersecurity Risk Assessments And Management Plans For Premarket Medical Device Submissions
The Food and Drug Administration has announced the availability of a new draft guidance document entitled "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices."
UK
3 Jul 2013
17
The French Act N°2011-2012 Dated 29 December 2011 Relating To The Reinforcement Of Health Security Of Medicinal And Health Products
This Act is focused on three main objectives: combating conflicts of interest and promoting transparency; strengthening the monitoring of medicinal products and medical devices; and making better information more readily available to patients and healthcare professionals and, in particular, establishing binding provisions covering the advertisement of drugs, medical and diagnostics devices.
France
23 Feb 2012
Links to Result pages
 
1